[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Tetracaine.]
[B03XA04, peginesatide, The risk or severity of Thrombosis can be increased when Peginesatide is combined with Asparaginase Escherichia coli.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Benzocaine.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Benzyl alcohol.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Bupivacaine.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Oxybuprocaine.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Capsaicin.]
[N03AF01, carbamazepine, The therapeutic efficacy of Carbamazepine can be increased when used in combination with Asparaginase Escherichia coli.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Chloroprocaine.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Dyclonine.]
[M02AA06, etofenamate, The therapeutic efficacy of Etofenamate can be increased when used in combination with Asparaginase Escherichia coli.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Levobupivacaine.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Cocaine.]
[L01EA01, imatinib, The risk or severity of liver damage can be increased when Asparaginase Escherichia coli is combined with Imatinib.]
[B03XA02, darbepoetin alfa, The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Asparaginase Escherichia coli.]
[M03CA01, dantrolene, The therapeutic efficacy of Dantrolene can be increased when used in combination with Asparaginase Escherichia coli.]
[S03BA01, dexamethasone, The serum concentration of Dexamethasone can be increased when it is combined with Asparaginase Escherichia coli.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Phenol.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Cinchocaine.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Pramocaine.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Diphenhydramine.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Ropivacaine.]
[N03AB01, ethotoin, The therapeutic efficacy of Ethotoin can be increased when used in combination with Asparaginase Escherichia coli.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Meloxicam.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Etidocaine.]
[C03CA01, furosemide, The therapeutic efficacy of Furosemide can be increased when used in combination with Asparaginase Escherichia coli.]
[S01XA14, heparin, The therapeutic efficacy of Heparin can be increased when used in combination with Asparaginase Escherichia coli.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Articaine.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Lidocaine.]
[M02AA18, meclofenamic acid, The therapeutic efficacy of Meclofenamic acid can be increased when used in combination with Asparaginase Escherichia coli.]
[N03AB04, mephenytoin, The therapeutic efficacy of Mephenytoin can be increased when used in combination with Asparaginase Escherichia coli.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Mepivacaine.]
[L04AX03, methotrexate, The therapeutic efficacy of Methotrexate can be decreased when used in combination with Asparaginase Escherichia coli.]
[N03AB05, fosphenytoin, The therapeutic efficacy of Fosphenytoin can be increased when used in combination with Asparaginase Escherichia coli.]
[B03XA03, methoxy polyethylene glycol-epoetin beta, The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Asparaginase Escherichia coli.]
[J01XE01, nitrofurantoin, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Asparaginase Escherichia coli.]
[N03AB02, phenytoin, The therapeutic efficacy of Phenytoin can be increased when used in combination with Asparaginase Escherichia coli.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Prilocaine.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Procaine.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Tetracaine.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Bupivacaine.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Oxybuprocaine.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Capsaicin.]
[N03AF01, carbamazepine, The therapeutic efficacy of Carbamazepine can be increased when used in combination with Asparaginase Erwinia chrysanthemi.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Chloroprocaine.]
[L01EX15, pexidartinib, Asparaginase Erwinia chrysanthemi may increase the hepatotoxic activities of Pexidartinib.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Dyclonine.]
[M02AA06, etofenamate, The therapeutic efficacy of Etofenamate can be increased when used in combination with Asparaginase Erwinia chrysanthemi.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Levobupivacaine.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Cocaine.]
[L01EA01, imatinib, The risk or severity of liver damage can be increased when Asparaginase Erwinia chrysanthemi is combined with Imatinib.]
[B03XA02, darbepoetin alfa, The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Asparaginase Erwinia chrysanthemi.]
[M03CA01, dantrolene, The therapeutic efficacy of Dantrolene can be increased when used in combination with Asparaginase Erwinia chrysanthemi.]
[S03BA01, dexamethasone, The serum concentration of Dexamethasone can be increased when it is combined with Asparaginase Erwinia chrysanthemi.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Phenol.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Cinchocaine.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Pramocaine.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Diphenhydramine.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Ropivacaine.]
[N03AB01, ethotoin, The therapeutic efficacy of Ethotoin can be increased when used in combination with Asparaginase Erwinia chrysanthemi.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Meloxicam.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Etidocaine.]
[C03CA01, furosemide, The therapeutic efficacy of Furosemide can be increased when used in combination with Asparaginase Erwinia chrysanthemi.]
[S01XA14, heparin, The therapeutic efficacy of Heparin can be increased when used in combination with Asparaginase Erwinia chrysanthemi.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Articaine.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Lidocaine.]
[M02AA18, meclofenamic acid, The therapeutic efficacy of Meclofenamic acid can be increased when used in combination with Asparaginase Erwinia chrysanthemi.]
[N03AB04, mephenytoin, The therapeutic efficacy of Mephenytoin can be increased when used in combination with Asparaginase Erwinia chrysanthemi.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Mepivacaine.]
[L04AX03, methotrexate, The therapeutic efficacy of Methotrexate can be decreased when used in combination with Asparaginase Erwinia chrysanthemi.]
[N03AB05, fosphenytoin, The therapeutic efficacy of Fosphenytoin can be increased when used in combination with Asparaginase Erwinia chrysanthemi.]
[B03XA03, methoxy polyethylene glycol-epoetin beta, The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Asparaginase Erwinia chrysanthemi.]
[J01XE01, nitrofurantoin, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Asparaginase Erwinia chrysanthemi.]
[N03AB02, phenytoin, The therapeutic efficacy of Phenytoin can be increased when used in combination with Asparaginase Erwinia chrysanthemi.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Prilocaine.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Procaine.]
[B03XA04, peginesatide, The risk or severity of Thrombosis can be increased when Peginesatide is combined with Asparaginase Erwinia chrysanthemi.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Benzocaine.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Benzyl alcohol.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Levobupivacaine.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Cocaine.]
[L01EA01, imatinib, The risk or severity of liver damage can be increased when Asparaginase Erwinia chrysanthemi is combined with Imatinib.]
[B03XA02, darbepoetin alfa, The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Asparaginase Erwinia chrysanthemi.]
[M03CA01, dantrolene, The therapeutic efficacy of Dantrolene can be increased when used in combination with Asparaginase Erwinia chrysanthemi.]
[S03BA01, dexamethasone, The serum concentration of Dexamethasone can be increased when it is combined with Asparaginase Erwinia chrysanthemi.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Phenol.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Cinchocaine.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Pramocaine.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Diphenhydramine.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Ropivacaine.]
[N03AB01, ethotoin, The therapeutic efficacy of Ethotoin can be increased when used in combination with Asparaginase Erwinia chrysanthemi.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Meloxicam.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Etidocaine.]
[C03CA01, furosemide, The therapeutic efficacy of Furosemide can be increased when used in combination with Asparaginase Erwinia chrysanthemi.]
[S01XA14, heparin, The therapeutic efficacy of Heparin can be increased when used in combination with Asparaginase Erwinia chrysanthemi.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Articaine.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Lidocaine.]
[M02AA18, meclofenamic acid, The therapeutic efficacy of Meclofenamic acid can be increased when used in combination with Asparaginase Erwinia chrysanthemi.]
[N03AB04, mephenytoin, The therapeutic efficacy of Mephenytoin can be increased when used in combination with Asparaginase Erwinia chrysanthemi.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Mepivacaine.]
[L04AX03, methotrexate, The therapeutic efficacy of Methotrexate can be decreased when used in combination with Asparaginase Erwinia chrysanthemi.]
[N03AB05, fosphenytoin, The therapeutic efficacy of Fosphenytoin can be increased when used in combination with Asparaginase Erwinia chrysanthemi.]
[B03XA03, methoxy polyethylene glycol-epoetin beta, The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Asparaginase Erwinia chrysanthemi.]
[J01XE01, nitrofurantoin, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Asparaginase Erwinia chrysanthemi.]
[N03AB02, phenytoin, The therapeutic efficacy of Phenytoin can be increased when used in combination with Asparaginase Erwinia chrysanthemi.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Prilocaine.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Procaine.]
